X

Dion Global Solutions Ltd. Stock Analysis

Small Cap
Evaluated by 227 users | BSE: 526927 | NSE: FORTISFIN |
IT - Software
Religare Technova Ltd. was incorporated on March 23, 1994 and received the Certificate of Commencement of Business on April 19. The Company was promoted by Ranbaxi Laboratories Ltd. and its associates. Religare Technova is the holding company for the IT business of a large diversified...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Return on Capital Employed -4.36%-5.37%-4.67%0.78%2.25%3.67%0.97%0.47%0.58%-154.74%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 323.230.734.134.240.335.234.428.624.1
Y-o-Y Gr. Rt.-672.1%32%11.1%0.5%17.7%-12.8%-2.2%-16.8%-15.8%
Adjusted EPS (Rs.) -2-3.79-4.99-4.72-0.39-0.4-3.27-3.5-5.22-101.03
Y-o-Y Gr. Rt.-NANANANANANANANANA
Book Value per Share (Rs.) 1.718.83478.0377.5977.1473.2569.5150.77-107.71
Adjusted Net Profit -8.1-16.6-21.9-15.2-1.3-1.3-10.5-11.3-16.8-326
Net Op. Cash Flow (Rs. Cr.) -1.161.5-5.40.1-2.76.712.61.3-6.83.4
Debt to Cash Flow from Ops -47.621.67-34.71748.71-50.319.3211.47114.33-33.86101.08
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Dion Global Solutions Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 26%-6.8%-11.9%-15.8%
Adjusted EPS NANANANA
Book Value per Share -258.5-206.8-213.7-312.2
Share Price -25.8% -53.2% -61.4% -25%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Return on Equity (%) -73.97-72.8-77.79-10.9-0.48-0.5-4.18-4.7-8.47354.84
Operating Profit Margin (%) -128-15.92-7.97-1.66-1.7212.94-6.06-8.15-37.24-131.28
Net Profit Margin (%) -268.87-71.45-71.37-44.65-3.69-3.19-29.97-32.85-58.89-1353.13
Debt to Equity 7.512.6510.650.370.520.50.590.641.4-0.99
Working Capital Days 3,9812112925496927861,2191,3661,9201,438
Cash Conversion Cycle 14984166189206206165104121147
Entity Percentage Holding
Promoters 20.18%
Institutions 17.12%
Non-Institutions 62.70%
Pledged *27.0226.6326.6324.6624.6641.380.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Dion Global Solution's performance infers:

Dion Global Solution earnings have grown by 0%, whereas share price has depreciated -53.2% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Dion Global Solution share prices over the last 10 years. Here is what we found out:

Dion Global Solution share price has depreciated -29.7% annually over the past ten years.

Religare Technova Ltd. was incorporated on March 23, 1994 and received the Certificate of Commencement of Business on April 19. The Company was promoted by Ranbaxi Laboratories Ltd. and its associates. 

Religare Technova is the holding company for the IT business of a large diversified Indian transnational business group. The group pursues aggressive business interests globally in Financial Services (Religare Enterprises), Health Care (Fortis HealthCare),
Religare Technova Ltd. was incorporated on March 23, 1994 and received the Certificate of Commencement of Business on April 19. The Company was promoted by Ranbaxi Laboratories Ltd. and its associates. 

Religare Technova is the holding company for the IT business of a large diversified Indian transnational business group. The group pursues aggressive business interests globally in Financial Services (Religare Enterprises), Health Care (Fortis HealthCare), Wellness (Religare Wellness, formerly Fortis HealthWorld), Diagnostics (Super Religare Laboratories, formerly SRL Ranbaxy) and Aviation and Travel (Religare Voyages).

The offerings of the company are divided into Products and Services. The Religare Technova umbrella includes Religare Technova Global Solutions (formerly Asian CERC Information Technology Ltd and Capital Market Solutions Pty Ltd), a global leader in providing Enterprise Software Solutions to the Capital and Financial markets; Religare Technova IT Services Limited, which provides Enterprise IT Solutions and Religare Technova Business Intellect Ltd, which provides Knowledge Management Solutions.

Currently with over 2000 employees and presence in over 10 countries, Religare Technova is poised to be a leader in the global IT space. Religare Technova focuses on clients in key verticals such as Banking and Financial Services, Insurance, Capital Markets and Health Sciences (Healthcare and Pharmaceuticals).

Products and services offered by the company:

The company is engaged in providing Capital Market Solutions , Information Security consulting ,Backup management services , Enterprise IT Solution, Trading Solutions ,Vendor Management Services and Banking & Financial Service solutions

Product
  • Trading Solution
  • Broking/Settlement Solution
  • Broking/Trading Solution
Services
  • Business Solution
  • Infrastructure Solution
  • Business Intellect
  • Knowledge Solution

Achievements/ recognition:
  • Religare Technova has been awarded membership of the elite Microsoft Dynamics President’s Club 2008. 
  • Amity HR Excellence Award’
  • Religare Technova has been appointed ASP for Lenovo. 
  • Cisco Premier Certified Partner

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback